Wei Wang

Profile photo of Wei Wang
Research Associate Professor
PHARMACOLOGICAL AND PHARMACEUTICAL SCIENCES
Health 2 Room 7040
Faculty Bio

Molecular targeting for cancer therapy, development experimental therapeutic agents and evaluation of their mechanism(s) of action, toxicity, and pharmacokinetics, especially for breast cancer treatment.


News

February 18, 2026
Research Targets Deadly Triple-negative Breast Cancer
March 24, 2024
The UH Drug Discovery Institute hosts John Buolamwini of Rosalind Franklin University.
June 6, 2023
Wei Li of the University of Tennessee Health Science Center demonstrates promising research on tubulin inhibitors for metastatic cancer.